Advertisement

Pharmacological Specificity Is Not the Same as Clinical Selectivity

  • S. A. Montgomery
  • D. James
  • D. B. Montgomery
Part of the Psychopharmacology Series book series (PSYCHOPHARM, volume 3)

Abstract

Numerous putative antidepressants are currently being developed on the basis of selective theories of action. Most such theories are derived from experiments in animal pharmacology and extrapolated to the ill human condition. These selective theories continue to be promoted despite the fact that currently available so-called selective antidepressants appear to have comparable levels of efficacy with each other and with the nonselective antidepressants. The long delay between production of compounds and the testing of their clinical efficacy in depressed patients might allow some to think that time-honoured theories could be accepted without proper testing in the clinic.

Keywords

Hamilton Rate Scale Adenylate Cyclase System Double Blind Condition Pharmacological Specificity Selective Subgroup 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aberg A (1981) Controlled cross-over study of a 5HT uptake inhibiting and an NA uptake inhibiting antidepressant. Acta Psychiatr Scand [Suppl] 290 (63): 244–255CrossRefGoogle Scholar
  2. D’Elia G, Hallstrom T, Nystrom C, Ottosson JO (1981) Zimelidine vs maprotiline in depressed outpatients. Acta Psychiatr Scand [Suppl] 290 (63): 225–235CrossRefGoogle Scholar
  3. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63PubMedGoogle Scholar
  4. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psych 6: 278–296CrossRefGoogle Scholar
  5. Montgomery SA, Asberg M (1979) A new depression scale designed to be more sensitive to change. Br J Psychiatry 134: 382–389PubMedCrossRefGoogle Scholar
  6. Montgomery SA, Roy DH, Montgomery DB (1984) HVA: a marker for suicidal acts? Prog Neuropsychopharmacol 8: 159–166Google Scholar
  7. Sulser F (1984) Antidepressant treatments and regulation of norepinephrine - receptor-coupled adenylate cyclase systems in brain. Front Biochem Pharmacol Res Depression 39: 249–261Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • S. A. Montgomery
    • 1
  • D. James
    • 1
  • D. B. Montgomery
    • 1
  1. 1.St Mary’s Hospital, Medical SchoolLondonEngland

Personalised recommendations